Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 20, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	91	147	42	15	27	5
Market Cap Growth	72.28%	246.10%	175.83%	-43.79%	420.70%	-50.67%
Enterprise Value	79	142	39	11	22	3
Last Close Price	0.08	0.14	0.05	0.02	0.06	0.03
PS Ratio	26.44	75.34	29.21	52.08	27.69	4.21
PB Ratio	7.90	13.10	11.24	2.02	3.05	1.27
P/TBV Ratio	7.90	13.10	11.24	2.06	3.10	1.32
EV/Sales Ratio	23.03	72.90	26.83	37.85	22.28	2.41
Debt / Equity Ratio	-	-	-	0.02	0.01	0.02
Asset Turnover	0.38	0.21	0.20	0.03	0.11	0.11
Inventory Turnover	-	-	-	-	-	6.68
Quick Ratio	10.82	6.32	3.08	4.05	4.28	0.97
Current Ratio	11.24	6.45	3.22	4.37	4.33	1.01
Return on Equity (ROE)	-85.35%	-116.55%	-178.67%	-103.87%	-76.96%	-46.72%
Return on Assets (ROA)	-45.61%	-59.16%	-73.48%	-47.72%	-28.43%	-22.13%
Return on Capital (ROIC)	-55.88%	-73.93%	-93.48%	-56.45%	-37.23%	-27.84%
Earnings Yield	-6.87%	-5.95%	-23.96%	-55.95%	-18.42%	-188.77%
FCF Yield	-7.18%	-4.79%	-15.06%	-40.91%	-13.54%	-57.47%
Buyback Yield / Dilution	-23.23%	-32.32%	-29.45%	-66.10%	-132.61%	-44.30%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.